Manning Paul B's Form 4 filing
Verrica Pharmaceuticals Inc. (VRCA) · filed Nov 26, 2024
- Accession no.
- 0001415889-24-027709
- Filed
- Nov 26, 2024
- Trade date
- Nov 22-26, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 4 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manning Paul BCIK 0001494695 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +18,426,966 | – | – | 26,278,094 | Direct | |
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +4,494,382 | – | – | 5,976,101 | Indirect | |
| Nov 26, 2024 | Common Stock | GGiftDisposed | −450,000 | $0.00 | $0 | 25,828,094 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +9,213,483 | – | – | 9,213,483 | Direct | |
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +9,213,483 | – | – | 9,213,483 | Direct | |
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +2,247,191 | – | – | 2,247,191 | Indirect | |
| Nov 22, 2024 | Common Stock | PPurchaseAcquired | +2,247,191 | – | – | 2,247,191 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.